Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1991 2
1993 2
1994 2
1995 3
1997 2
1998 1
2000 2
2002 1
2006 1
2007 1
2008 1
2009 2
2010 2
2011 2
2012 1
2015 1
2016 1
2017 1
2019 1
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer.
Dirix L, Buys A, Oeyen S, Peeters D, Liègeois V, Prové A, Rondas D, Vervoort L, Mariën V, Laere SV, Vermeulen P. Dirix L, et al. Among authors: prove a. Breast Cancer Res Treat. 2022 Jun;193(2):437-444. doi: 10.1007/s10549-022-06585-5. Epub 2022 Apr 9. Breast Cancer Res Treat. 2022. PMID: 35397078 Free PMC article.
A phase II study of the combination of endocrine treatment and bortezomib in patients with endocrine-resistant metastatic breast cancer.
Trinh XB, Sas L, Van Laere SJ, Prové A, Deleu I, Rasschaert M, Van de Velde H, Vinken P, Vermeulen PB, Van Dam PA, Wojtasik A, De Mesmaeker P, Tjalma WA, Dirix LY. Trinh XB, et al. Among authors: prove a. Oncol Rep. 2012 Mar;27(3):657-63. doi: 10.3892/or.2011.1562. Epub 2011 Nov 24. Oncol Rep. 2012. PMID: 22134540 Clinical Trial.
Neratinib for the treatment of breast cancer.
Prové A, Dirix L. Prové A, et al. Expert Opin Pharmacother. 2016 Nov;17(16):2243-2248. doi: 10.1080/14656566.2016.1244528. Epub 2016 Oct 17. Expert Opin Pharmacother. 2016. PMID: 27690680
Inflammatory breast cancer: current understanding.
Dirix LY, Van Dam P, Prové A, Vermeulen PB. Dirix LY, et al. Among authors: prove a. Curr Opin Oncol. 2006 Nov;18(6):563-71. doi: 10.1097/01.cco.0000245307.29026.0a. Curr Opin Oncol. 2006. PMID: 16988576 Review.
Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer.
Van der Auwera I, Peeters D, Benoy IH, Elst HJ, Van Laere SJ, Prové A, Maes H, Huget P, van Dam P, Vermeulen PB, Dirix LY. Van der Auwera I, et al. Among authors: prove a. Br J Cancer. 2010 Jan 19;102(2):276-84. doi: 10.1038/sj.bjc.6605472. Epub 2009 Dec 1. Br J Cancer. 2010. PMID: 19953098 Free PMC article.
31 results